Author

A. Menard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Lok· 1 shared B. La Scola· 1 shared B. Mahe· 1 shared C. Cano· 1 shared C. Varon· 1 shared D. Olive· 1 shared E. Foucher· 1 shared E. Sifre· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Lok

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Vγ9Vδ2 T cells are potent inhibitors of SARS-CoV-2 replication and exert effector phenotypes in COVID-19 patients

L. Gay, M.-S. Rouviere, S. Mezouar, M. Richaud, L. Gorvel, E. Foucher, L. Madakamutil, B. La Scola, A. Menard, J. Allardet-Servent, P. Halfon, P. Frohna, C. Cano, J.-L. Mege, D. Olive

This paper investigates how SARS-CoV-2 affects Vγ9Vδ2 T cells in patients and shows that anti-BTN3A activation enhances their antiviral response.

bioRxiv · Apr 15, 2022 · PreprintImmunology

The cytolethal distending toxin modulates cell differentiation and elicits epithelial to mesenchymal transition

L. AZZi-MARTIN, V. Touffait-Calvez, M. Everaert, R. Jia, E. Sifre, L. Seeneevassen, C. Varon, P. Dubus, A. Menard

This study shows that CdtB induces epithelial to mesenchymal transition in mouse and human cells, promoting cancer progression through increased cell motility and mesenchymal marker expression.

bioRxiv · Apr 6, 2022Microbiology

Reliable one-step assessment of IGHV mutational status and gene mutations in Chronic Lymphocytic Leukemia by capture-based high throughput sequencing.

Y. Le Bris, F. Thonier, A. Menard, O. Theisen, B. Mahe, A. Lok, S. Bouzy, M. C. Bene

This paper develops a single-step capture-based HTS method to simultaneously assess IGHV mutational status and TP53 mutations in CLL patients, validated on retrospective and prospective cohorts.

bioRxiv · Mar 9, 2022 · PreprintCancer Biology